Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy?

Michael S. Sabel, Ellis G. Levine, Thelma Hurd, Gary N. Schwartz, Robert Zielinski, David Hohn, Stephen B. Edge

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences